✦ LIBER ✦

Discovery of Potent, Orally Bioavailable Small-Molecule Inhibitors of the Human CCR2 Receptor

✍ Scribed by Julien Doyon; Erwin Coesemans; Staf Boeckx; Mieke Buntinx; Bart Hermans; Jean P. Van Wauwe; Ron A. H. J. Gilissen; Alex H. J. De Groot; David Corens; Guy Van Lommen

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 293 KB
Volume: 3
Category: Article
ISSN: 1860-7179
DOI: 10.1002/cmdc.200700276

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Orally Bioavailable Small Molecule Ketoa

Orally Bioavailable Small Molecule Ketoamide-Based Inhibitors of Cathepsin K

✍ David G. Barrett; John G. Catalano; David N. Deaton; Stacey T. Long; Larry R. Mi 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 23 KB 👁 1 views

## Abstract For Abstract see ChemInform Abstract in Full Text.

Antagonists of Human CCR5 Receptor Conta

Antagonists of Human CCR5 Receptor Containing 4-(Pyrazolyl)piperidine Side Chains. Part 2. Discovery of Potent Selective, and Orally Bioavailable Compounds.

✍ Dong-Ming Shen; et al. et al. 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 65 KB 👁 2 views

## Abstract For Abstract see ChemInform Abstract in Full Text.

ChemInform Abstract: Discovery of INCB33

ChemInform Abstract: Discovery of INCB3344 (I), a Potent, Selective and Orally Bioavailable Antagonist of Human and Murine CCR2.

✍ Chu-Biao Xue; et al. et al. 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 21 KB 👁 1 views

Hit-to-Lead Studies: The Discovery of Po

Hit-to-Lead Studies: The Discovery of Potent, Orally Bioavailable Thiazolopyrimidine CXCR2 Receptor Antagonists.

✍ Andrew Baxter; Anne Cooper; Elizabeth Kinchin; Kerry Moakes; John Unitt; Alan Wa 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 12 KB 👁 2 views

Discovery of Potent and Orally Bioavaila

Discovery of Potent and Orally Bioavailable N,N′-Diarylurea Antagonists for the CXCR2 Chemokine Receptor.

✍ Qi Jin; et al. et al. 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 21 KB 👁 2 views

Discovery and Synthesis of a Potent, Sel

Discovery and Synthesis of a Potent, Selective and Orally Bioavailable EP4 Receptor Agonist

✍ Robert N. Young; et al. et al. 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 9 KB 👁 2 views